Cemtrex Reports 17% Revenue Growth to $16.1 Million, Faces Increased Operating Loss

Cemtrex, Inc. reported its financial results for the three months ending December 31, 2025, revealing a revenue increase to $16.1 million, up from $13.7 million in the same period last year, marking a growth of approximately 17%. The company's gross profit for the quarter was $5.6 million, representing a gross margin of 35%, a decline from 41% in the prior year. The operating loss widened to $2.8 million compared to a loss of $2.3 million in the previous year, primarily due to increased general and administrative expenses and interest costs.

The company experienced significant changes in its financial position, with total assets rising to $60.3 million from $47.8 million at the end of the previous quarter. Cash and cash equivalents surged to $20.5 million, up from $5.0 million, largely due to successful equity offerings and warrant exercises. However, total liabilities decreased to $31.2 million from $39.1 million, reflecting a reduction in current liabilities and long-term debt. The net loss attributable to Cemtrex stockholders was $20.6 million, a decrease from $28.8 million in the prior year, indicating improved performance despite ongoing challenges.

Strategically, Cemtrex has made notable acquisitions, including the purchase of Invocon for $7.1 million, which will enhance its Aerospace and Defense segment, and the acquisition of Richland Industries for $600,000, expanding its Industrial Services segment. These acquisitions are expected to contribute to revenue growth and operational efficiency in the upcoming quarters. The company also reported a significant increase in its employee headcount, reflecting its expansion efforts.

Operationally, Cemtrex's Security segment generated $5.5 million in revenue, a slight increase from the previous year, while the Industrial Services segment saw a 28% increase in revenue to $10.6 million. The company reported a decrease in trade receivables, down 26% to $9.7 million, attributed to reduced sales compared to the previous quarter. The company also noted a decrease in research and development expenses, which fell by 44% to $501,435, as it focused on cost management.

Looking ahead, Cemtrex's management expressed cautious optimism, highlighting plans to improve margins through pricing adjustments and operational efficiencies. The company aims to leverage its cash reserves and credit facilities to support ongoing operations and growth initiatives. However, management acknowledged substantial doubt regarding its ability to continue as a going concern, emphasizing the need for additional capital to meet its obligations over the next twelve months. The company is actively exploring options to raise further equity and restructure its debt to ensure financial stability.